Issue |
Section |
Title |
File |
Vol 79, No 3 (2004) |
Editorial |
Obliterating bronchiolytis induced by D-penicillamine in a female patient with systemic sclerosis |
|
Vol 79, No 11 (2004) |
Editorial |
Exacerbated chronic obstructive pulmonary disease: current trends in diagnosis and treatment (review) |
|
Vol 80, No 8 (2008) |
Editorial |
Is it possible to modify the course of chronic obstructive pulmonary disease with modern medication? |
|
Vol 81, No 3 (2009) |
Editorial |
Thiotropium in bronchial asthma |
|
Vol 83, No 9 (2011) |
Editorial |
Pandemic flu in Russia: special features of a clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease |
|
Vol 84, No 12 (2012) |
Editorial |
Current guidelines for oxygen therapy in emergency care |
|
Vol 85, No 3 (2013) |
Editorial |
First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study |
|
Vol 86, No 3 (2014) |
Editorial |
Choice of novel endpoints in clinical trials evaluating the efficiency of drug therapy in patients with pulmonary hypertension |
|
Vol 86, No 9 (2014) |
Editorial |
Clinical guidelines for the diagnosis and treatment of pulmonary hypertension |
|
Vol 86, No 10 (2014) |
Editorial |
The 2013-2014 epidemic season. Hospital monitoring and antiviral therapy for influenza |
|
Vol 87, No 9 (2015) |
Editorial |
Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan |
|
Vol 88, No 7 (2016) |
Editorial |
The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension |
 (Rus)
|
Vol 88, No 8 (2016) |
Editorial |
Expert Panel Resolution on Personified Choice of an Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary Diseas |
 (Rus)
|
Vol 89, No 1 (2017) |
Editorial |
Idiopatic pulmonary fibrosis: A new paradigm |
 (Rus)
|
Vol 89, No 9 (2017) |
Editorial |
A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out? |
 (Rus)
|
Vol 91, No 12 (2019) |
Editorial |
Clinical and economic analysis of Reslizumab use in the treatment of patients with severe allergic eosinophilic asthma |
 (Rus)
|